News ArchivesRead News

Parkinson's disease is caused by a 'genetic defect' claim scientists

Sunday August 11, 2013

Anna Edwards

Daily Mail (UK) - Parkinson's disease is caused by a genetic defect that produces poor 'housekeeping cells', claim scientists who believe they are closer to treating the debilitating condition.

Research has linked the disease to a genetic defect that stops cells clearing out defective mitochondria, tiny metabolic generators that supply energy.

Dysfunctional mitochondria are potentially very harmful.
Cells normally dispose of them through a 'hazardous waste' management system called mitophagy that causes the bean-like bodies to be digested and broken down.

Scientists have now discovered a biological pathway that allows mutations in a gene called FBxo7 to interfere with mitophagy.

In people with Parkinson's, this leads to a build-up of defective mitochondria that may result in the death of brain cells.

The study, published in the journal Nature Neuroscience, indicates that mitophagy might be the key to new treatment options for the disease.

Dr Helene Plun-Favreau, one of the researchers from the University College London Institute of Neurology, said: 'These findings suggest that treatment strategies that target mitophagy might be developed to benefit patients with Parkinson's disease in the future.

'What makes the study so robust is the confirmation of defective mitophagy in a number of different Parkinson's models, including cells of patients who carry a mutation in the Fbxo7 gene.'

Co-author Dr Heike Laman, from Cambridge University, said: 'This research focuses the attention of the Parkinson's disease community on the importance of the proper maintenance of mitochondria for the health of neurons.

'We are really only at the very beginning of this work, but perhaps we can use this information to enable earlier diagnosis for Parkinson's disease patients or design therapies aimed at supporting mitochondrial health.'

Professor Hugh Perry, chair of the neurosciences and mental health board at the Medical Research Council which part-funded the study, said the work raised 'interesting questions' about brain cell death related to Parkinson's.

'The more we understand about the basic molecular events which contribute to the onset and progression of Parkinson's disease, the better placed we will be to develop treatments to stop it in its tracks,' he said.

Recent News

Nov 22 - A caregiver's story: Living and loving through the slow process of dying
Nov 19 - Testosterone cause of sex differences in the occurrence of Parkinson’s disease, new research suggests
Nov 18 - New strategy reduces side effects in Parkinson's treatment
Nov 14 - Opinion: The never-ending tests of Parkinson's disease
Nov 13 - Parkinson’s disease: A new tool for diagnosis
Nov 10 - Parkinson's Disease Drug May Be Useful For Delaying, Preventing Blindness In Older Population
Nov 9 - Microsoft VP’s diagnosis fuels employees’ heartfelt efforts to help others
Nov 6 - Lewy body dementia: unrecognized and misdiagnosed
Nov 5 - Gait difficulties in Parkinson's linked to new blood vessels in brain
Oct 30 - Special Section: Enabling Technologies for Parkinson’s Disease Management
Oct 27 - Scientists discover a 'switchboard' of molecules that protect against Parkinson's disease
Oct 26 - Dancing improves mobility and quality of life in people with Parkinson's
Oct 23 - The amazing woman who can smell Parkinson’s disease — before symptoms appear
Oct 20 - Personal Essay: The deviousness of dementia
Oct 19 - Mechanism that 'melts' protein clumps may lead to new Parkinson's treatments
Oct 19 - Researchers find that stem cell treatment may reduce cognitive impairment related to dementia with Lewy bodies
Oct 17 - Cancer Drug Helps Parkinson's Patients
Oct 12 - Researchers identify immune gene that can prevent Parkinson's disease and dementia
Oct 12 - Blog Post: An Alert, Well-Hydrated Artist in No Acute Distress
Oct 7 - This month, a brain surgery will be broadcast on live TV for the first time ever